Joel Donelly's retail pharmacy, located in the lobby of a Kingston, Ont. hospital is making major strides to improve the delivery of therapy and pharmaceutical care to vulnerable populations.
Alberta has become the third province in Canada to fund the Fluzone High-Dose influenza vaccine for all adults aged 65 and older, beginning with 2021-2022 season.
Sanofi will build a new vaccine manufacturing facility in Toronto, Ontario, to increase the supply of its Fluzone High-Dose quadrivalent influenza vaccine in Canada, the U.S. and Europe.